【Press Release】Unlocking Asian Technologies for the World.
Launch of “iDCP,” a Life Science-Focused Matching Platform

Press Release

Jan 15, 2026
iPark Institute Co., Ltd.

Unlocking Asian Technologies for the World.
Launch of “iDCP,” a Life Science-Focused Matching Platform
~Accelerating partnerships between investors and pharmaceutical companies and startups and academia through AI-driven automated structuring~

iPark Institute Co., Ltd. (Head Office: Fujisawa, Kanagawa; CEO: Toshio Fujimoto; hereinafter “iPark Institute”) announces the launch of iDCP (iPark Digital Community Platform), a digital matching platform designed to promote global partnership formation in the life sciences field, scheduled to launch on March 1, 2026.
▼For more information on iDCP
https://www.shonan-ipark.com/en/news/2537/ttps://ipark-dcp.com/lp/en/1?utm_source=pr&utm_medium=referral&utm_campaign=idcp_launch_202601_jp

Background to the Development of iDCP
In the life sciences sector, compared with technologies originating in Europe and the United States, outstanding technologies developed by startups and academic institutions in Asia are often not fully recognized by global investors and pharmaceutical companies. This “black box” of information has become a key challenge.

At the same time, startups and academic institutions in Asia face multiple issues, including:
• Uncertainty regarding the information sought by overseas venture capital firms, and corporations
• The burden of information preparation and multilingual support
• Barriers to building global networks
With the concept of “unlocking Asian technologies and information,” iDCP is designed to structurally address these challenges and accelerate encounters between global investors and innovative technologies.

Key Features of iDCP
1. AI-driven automatic matching between the areas of interest if venture capital firms and pharmaceutical companies and the technological information of startups and academic institutions
2. Automatic structuring and optimization of technology information entered by startups and academia into formats tailored for investors and pharmaceutical companies, using multilingual AI
3. Access to highly reliable confidential information through the execution of NDAs on the iDCP platform

Launch Campaign
Ahead of the official release on March 1, 2026, pre-registration will be opened. An early-access period allowing free use of the platform will be offered until the end of September 2026.
Startups, academic institutions, investors and pharmaceutical companies interested in this service are encouraged to take advantage of this opportunity by registering early and utilizing iDCP.

▼Please register via the QR code or the link below

https://ipark-dcp.com/signup?utm_source=pr&utm_medium=referral&utm_campaign=idcp_launch_202601_en

About iPark Institute Co., Ltd.
iPark Institute Co., Ltd. was established in 2023 with Industrial & Infrastructure Fund Investment Corporation (IIF), Takeda Pharmaceutical Company Limited (Takeda), and Mitsubishi Corporation as major shareholders. It took over the management of Shonan Health Innovation Park (Fujisawa City, Kanagawa Prefecture) in 2023, which Takeda has been responsible for since 2018. For more information about our company, please click here.

About Shonan Health Innovation Park (Shonan iPark)
Shonan iPark is Japan’s first pharmaceutical-initiated science park, created by Takeda Pharmaceutical Company Limited in April 2018 by opening its own research laboratories to the outside world. Currently operated by iPark Institute Co., Ltd. independent of Takeda Pharmaceutical Company Limited, the park aims to become a place where industry, government, and academia from a wide range of industries and sizes can come together to accelerate health innovation. Currently, the ecosystem is comprised of not only pharmaceutical companies, but also companies and organizations in next generation medicine, cellular agriculture, AI, and government, with approximately 220 companies and more than 3,500 people (as of January 2026).

Click here for homepage

For the latest information on tenants and member companies at Shonan iPark, click click here.

Official social links: YouTube / Facebook / X (former Twitter) / LinkedIn

For inquiries regarding this matter, please contact:
iPark Institute Co., Ltd., Communications
Attn: Sugita, Tsukahara
Mail: iPi.PR@shonan-ipark.com